Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|32|3485-3507

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.32, 2017-10, pp. : 3485-3507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ras Signaling Pathway Proteins as Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1581-1594

Bentham Science Publishers

Access to resources Recommend Favorite

Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-03 ,pp. : 391-403

Bentham Science Publishers

Access to resources Recommend Favorite

HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers

By Manzo-Merino Joaquin   Thomas Miranda   Fuentes-Gonzalez Alma M   Lizano Marcela   Banks Lawrence  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1357-1368

Informa Healthcare

Access to resources Recommend Favorite

The mTOR Signaling Pathway is an Emerging Therapeutic Target in Multiple Myeloma

By  

Current Pharmaceutical Design, Vol. 20, Iss. 1, 2014-01 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

Agents Targeting Ras Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2259-2267

Bentham Science Publishers

Access to resources Recommend Favorite